This potent SFK inhibitor decreases the autophosphorylation of Src kinase and consequently reduces downstream signaling from Src to Akt in GBM cell lines [11], inhibiting their proliferation and invasive potential [12,13]. The gene discussed is SRC; the disease is glioblastoma.